Insider · CIK 0001829958

Durgam Suresh K.

Reports to the SEC for 1 company · BEDMINSTER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001829958

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−24.6K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−17.5K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−13.1K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−17.9K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−18.7K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−33.4K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−54K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−42.9K sh	$132.00	−$5.66M	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	EVP, Chief Medical Officer	AAward	+13.1K sh	—	—	13,134
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−13.1K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	EVP, Chief Medical Officer	AAward	+8,742 sh	—	—	8,742
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	EVP, Chief Medical Officer	DDisposition to Issuer	−8,742 sh	—	—	0
2025-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−7,345 sh	—	—	0
2025-03-10	Intra-Cellular Therapies, Inc.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−3,116 sh	$131.24	−$409K	42,913
2025-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+7,345 sh	—	—	46,029
2025-03-06	Intra-Cellular Therapies, Inc.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−5,572 sh	$131.19	−$731K	38,684
2025-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+13.1K sh	—	—	44,256
2025-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−13.1K sh	—	—	13,133
2025-03-01	Intra-Cellular Therapies, Inc.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−3,709 sh	$128.20	−$475K	31,123
2025-03-01	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+8,742 sh	—	—	34,832
2025-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−8,742 sh	—	—	17,485
2025-02-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	EVP, Chief Medical Officer	AAward	+24.6K sh	—	—	24,621
2025-01-31	Intra-Cellular Therapies, Inc.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−4,730 sh	$127.00	−$601K	26,090
2025-01-31	Intra-Cellular Therapies, Inc.A Award	EVP, Chief Medical Officer	AAward	+11K sh	—	—	30,820
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−872 sh	$65.89	−$57.5K	20,464
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−2,179 sh	$65.06	−$142K	21,336
2024-03-11	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−661 sh	$66.96	−$44.3K	19,803
2024-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−7,345 sh	—	—	7,345
2024-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+7,345 sh	—	—	23,515
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−2,722 sh	$66.86	−$182K	16,170
2024-03-07	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−3,728 sh	$66.34	−$247K	18,892
2024-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−13.1K sh	—	—	26,266
2024-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+13.1K sh	—	—	22,620
2024-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	EVP, Chief Medical Officer	AAward	+26.2K sh	—	—	26,227
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−1,312 sh	$71.02	−$93.2K	9,488
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−1,400 sh	$69.38	−$97.1K	12,200
2024-02-26	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−1,400 sh	$70.16	−$98.2K	10,800
2024-02-23	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−7,907 sh	—	—	0
2024-02-23	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+7,907 sh	—	—	13,600
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−2,320 sh	$66.69	−$155K	9,540
2024-02-02	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−3,847 sh	$67.49	−$260K	5,693
2024-02-01	Intra-Cellular Therapies, Inc.A Award	EVP, Chief Medical Officer	AAward	+11.9K sh	—	—	11,860
2024-01-02	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−2,210 sh	$71.77	−$159K	0
2024-01-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	−62.3K sh	—	—	0
2024-01-02	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−22.6K sh	$70.80	−$1.6M	2,210
2024-01-02	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−37.4K sh	$70.41	−$2.64M	24,855
2024-01-02	Intra-Cellular Therapies, Inc.M Exercise/Conversion	EVP, Chief Medical Officer	MExercise/Conversion	+62.3K sh	$19.87	+$1.24M	62,282
2023-12-13	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−21.3K sh	$65.00	−$1.38M	0
2023-07-17	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−1,842 sh	$65.00	−$120K	21,262
2023-03-13	Intra-Cellular Therapies, Inc.S Sale	EVP, Chief Medical Officer	SSale	−346 sh	$44.29	−$15.3K	23,104

Recent filings

Accepted (ET)
Apr 24
Durgam Suresh K.0000950170-25-049593
SEC(opens sec.gov)
Mar 104
Durgam Suresh K.0000950170-25-036594
SEC(opens sec.gov)
Mar 44
Durgam Suresh K.0000950170-25-032584
SEC(opens sec.gov)

Companies

Intra-Cellular Therapies, Inc.EVP, Chief Medical Officer

Address

C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206, SUITE 6

BEDMINSTER, NJ, 07921